American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.

Autor: Pennell NA; Cleveland Clinic, Cleveland, OH., Dillmon M; Harbin Clinic LLC, Rome, GA., Levit LA; American Society of Clinical Oncology, Alexandria, VA., Moushey EA; American Society of Clinical Oncology, Alexandria, VA., Alva AS; University of Michigan, Ann Arbor, MI., Blau S; Northwest Medical Specialties, Seattle, WA., Cannon TL; INOVA Medical Group, Fairfax, VA., Dickson NR; Tennessee Oncology, Nashville, TN., Diehn M; Stanford University, Stanford, CA., Gonen M; Memorial Sloan-Kettering Cancer Center, New York, NY., Gonzalez MM; Virginia Mason Medical Center, Seattle, WA., Hensold JO; Bozeman Deaconess Health Services, Bozeman, MT., Hinyard LJ; Saint Louis University, St Louis, MO., King T; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA., Lindsey SC; Cholangiocarcinoma Foundation, Herriman, UT., Magnuson A; University of Rochester, Rochester, NY., Marron J; Boston Children's Hospital, Boston, MA., McAneny BL; New Mexico Oncology Hematology Consultants, Ltd, Albuquerque, NM., McDonnell TM; Seattle Cancer Care Alliance, Seattle, WA., Mileham KF; Levine Cancer Institute, Charlotte, NC., Nasso SF; National Coalition for Cancer Survivorship, Silver Spring, MD., Nowakowski GS; Mayo Clinic, Rochester, MN., Oettel KR; Gundersen Health System, La Crosse, WI., Patel MI; Stanford University, Stanford, CA., Patt DA; Texas Oncology PA, Austin, TX., Perlmutter J; Gemini Group, Ann Arbor, MI., Pickard TA; University of Texas MD Anderson Cancer Center, Houston, TX., Rodriguez G; START Center for Cancer Care, San Antonio, TX., Rosenberg AR; University of Washington, Seattle, WA., Russo B; The Center for Cancer and Blood Disorders, Fort Worth, TX., Szczepanek C; Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI., Smith CB; Icahn School of Medicine at Mt. Sinai, Bronxville, NY., Srivastava P; Kaiser Permanente Northern California, Walnut Creek, CA., Teplinsky E; Valley Health System, Paramus, NJ., Thota R; Intermountain Healthcare, South Jordan, UT., Traina TA; Memorial Sloan-Kettering Cancer Center, New York, NY., Zon R; Michiana Hematology Oncology, Niles, MI., Bourbeau B; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Foster S; Association for Clinical Oncology, Alexandria, VA., Grubbs S; American Society of Clinical Oncology, Alexandria, VA., Hagerty K; Association for Clinical Oncology, Alexandria, VA., Hurley P; American Society of Clinical Oncology, Alexandria, VA., Kamin D; American Society of Clinical Oncology, Alexandria, VA., Phillips J; American Society of Clinical Oncology, Alexandria, VA., Schenkel C; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA., Burris HA 3rd; Sarah Cannon, Nashville, TN.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jan 10; Vol. 39 (2), pp. 155-169. Date of Electronic Publication: 2020 Dec 08.

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.

Autor: Reinisch W; McMaster University, Hamilton, Ontario, Canada Medical University of Vienna, Vienna, Austria., Panés J; Hospital Clinic I Provincial de Barcelona, CIBERehd, IDIBAPS, Barcelona, Spain., Khurana S; Premier Medical Group, Fishkill, New York, USA., Toth G; Szent János Hospital, Budapest, Hungary., Hua F; Pfizer Inc, Collegeville, Pennsylvania, USA., Comer GM; Pfizer Inc, Collegeville, Pennsylvania, USA., Hinz M; Pfizer Inc, Collegeville, Pennsylvania, USA., Page K; Pfizer Inc, Collegeville, Pennsylvania, USA., O'Toole M; Pfizer Inc, Collegeville, Pennsylvania, USA., Moorehead TM; InVentiv Health Clinical, Burlington, Massachusetts, USA., Zhu H; Pfizer CRDC, Shanghai, China., Sun Y; Pfizer CRDC, Shanghai, China., Cataldi F; Pfizer Inc, Collegeville, Pennsylvania, USA.

Publikováno v: Gut [Gut] 2015 Jun; Vol. 64 (6), pp. 894-900. Date of Electronic Publication: 2015 Jan 07.

Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential.

Autor: Spencer TJ; Massachusetts General Hospital, Boston, MA 02114, USA. tspencer@partners.org, Biederman J, Martin JM, Moorehead TM, Mirto T, Clarke A, Batchelder H, Faraone SV

Publikováno v: Postgraduate medicine [Postgrad Med] 2012 Jan; Vol. 124 (1), pp. 166-73.